Prospects and challenges of in vivo hematopoietic stem cell genome editing for hemoglobinopathies
Mol Ther
.
2023 Oct 4;31(10):2823-2825.
doi: 10.1016/j.ymthe.2023.09.006.
Epub 2023 Sep 19.
Authors
André Lieber
1
,
Hans-Peter Kiem
2
Affiliations
1
University of Washington, Seattle, WA, USA.
2
University of Washington, Seattle, WA, USA; Fred Hutchinson Cancer Center, Seattle, WA, USA. Electronic address: hkiem@fredhutch.org.
PMID:
37729905
PMCID:
PMC10556215
(available on
2024-10-04
)
DOI:
10.1016/j.ymthe.2023.09.006
No abstract available